Modulation of Inflammation-Driven Hepatocarcinogenesis: The Hepatic Immune Microenvironment, Gut-Liver Axis, and Neuroregulation. [PDF]
Yu W, Yin K, Liu C, Ding J, Shi Y.
europepmc +1 more source
Etiology-Driven Mouse Models of Hepatocellular Carcinoma: Paving the Way for Precision Oncology. [PDF]
Cao W, Fan Y, Chen H, Sun J, Jin X.
europepmc +1 more source
Caffeine in the Context of Sorafenib Chemotherapy: Insights From Experimental Hepatocarcinogenesis. [PDF]
Valente LC +5 more
europepmc +1 more source
Therapeutic potential and molecular mechanisms of citrus flavonoids in hepatocellular carcinoma. [PDF]
Zhu X +5 more
europepmc +1 more source
Molecular Basis and Clinical Significance of the High-risk Phenotype of Hepatitis B Virus Genotype C. [PDF]
Huang C, Liu Z, Zhang J, Shen T, Sang L.
europepmc +1 more source
Microbiome-Immune Interactions as Determinants of Checkpoint Inhibitor Efficacy in Hepatocellular Carcinoma. [PDF]
Ostafe MR +8 more
europepmc +1 more source
Dietary Polyphenols and Selected Nutraceuticals in Hepatocellular Carcinoma: Mechanistic Insights, Translational Evidence, and Clinical Prospects. [PDF]
Arshad F +5 more
europepmc +1 more source
Correction to: Degradation of helicase-like transcription factor (HLTF) by ß-TrCP promotes hepatocarcinogenesis via activation of the p62/mTOR axis. [PDF]
europepmc +1 more source
Multi-target Mechanisms and Clinical Evidence for Ganzaoning Granule in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review. [PDF]
Zhao H.
europepmc +1 more source
Hepatocellular Carcinoma Precursor Lesions: From Pathological Basis to Risk Stratification and Precision Intervention. [PDF]
Yan R +8 more
europepmc +1 more source

